As per the report, the global cell culture industry size is expected to upsurge with mega-trends stem cell therapy and regenerative medicine. It redefined the ecosystem in life science, biotechnology and biopharmaceutical research activities. There are many examples related to this, such as developments in cell culture technology that have used food developers to use animal cells to produce food.
After this trend was highlighted, it is now suggesting 3D cell culture could be highly sought-after in drug development entailing tissue engineering and biopharmaceutical manufacturing. Top Investors and researchers have said that 3D cell culture technology can enhance its role. It should solidifying its position as one of the essential tools in regenerative medicine, disease modelling and drug discovery. Currently, spheroids have changed or you can say it has gained momentum for the growth and development of anticancer therapies faster.
3D tumor models is playing a major role in pre-clinical research. De facto, 3D cell culture has gained ground in regenerative medicine. The market size of global 3D cell culture was valued at USD 1.74 billion two years ago. Research says it has been expected to reach a CAGR of 10.74% from 2022 to 2030.
The sources say that Stakeholders have raised investments in cell culture media (CCM). They have raised this huge amount against the backdrop of the infusion of funds which is related to vaccines and monoclonal antibodies. The FDA has already approved cell-based vaccines which boded well for leading players gearing up to bolster their footprint. Two years ago in October, the FDA approved the approval from Seqirus for its cell-based quadrivalent influenza vaccine. The global cell culture media market size grabbed the amount of $3.62 billion in 2021 and they believe a CAGR of 12.13% will touch before 2030.
By seeing stem cells becoming instrumental in medicine and therapies, many top-notch companies are looking to shape the dynamics like a spike in oncology-based research and the expanding applications of gene therapy have spurred the demand for cell culture. Moreover, Enzymatic disaggregation was grabbed in primary cell culture. The purpose was cell disaggregation for raising representation samples. In addition to this, Asia Pacific market believe that they will provide a promising growth potential related to research activities in regenerative medicines and oncology.